Work

Phase I Study of Aurora Kinase Inhibitor MLN8237 and Bortezomib in Relapsed or Refractory Multiple Myeloma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.1859.1859

Authors: A. Keith Stewart, Ravi Vij, Jacob P. Laubach, Craig C. Hofmeister, Rachel Hagerty, Amylou C. Dueck, Shaji K. Kumar

Institutions: Mayo Clinic in Arizona, Washington University in St. Louis, Dana-Farber Cancer Institute, The Ohio State University, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587660273

FWCI: 0.577

Cites:

Cited by: 3

Related to: 10